In this study, we find Nrf2 serves as a novel regulator of PDGFA that significantly transactivates its mRNA transcripts, which subsequently activates the AKT/p21 pathway, resulting in increased cell cycle progression of HCC cells. This evidence concerns the gene NFE2L2 and hepatocellular carcinoma.